Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 609 participants.

Also called NCT04676880

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 609 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04676880
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04676880. Randomized; no masking; primary purpose prevention. Start 2021-01-01 (actual); primary completion 2026-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy
Acronym
COMPARE-LAAO
Condition
Anticoagulants and Bleeding Disorders
Intervention (Device)
Left atrial appendage occlusion (Watchman FLX or Amplatzer Amulet)
Lead sponsor
R&D Cardiologie (class: other)
Collaborator
ZonMw: The Netherlands Organisation for Health Research and Development (class: other)

Record details

Record id
cardio:ct-nct04676880
Content hash
69bdf21058f482dce5659aab6c694d9c8fbd64ad8ab636746019603db73240aa